Home   >  
GPCR/G Protein
Prostaglandin Receptor

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products






Raw Materials

Prostaglandin Receptor

Chemical Structure Cat. No. Product Name CAS No.
Carboprost tromethamine Chemical Structure
BCP28453 Carboprost tromethamine 58551-69-2
Carboprost tromethamine is the synthetic 15-methyl analogue of prostaglandin F2α. Carboprost tromethamine can effectively promote law contraction of the uterus and significantly reduce the amount of bleeding during and after delivery.
Tranilast sodium Chemical Structure
BCP46779 Tranilast sodium 104931-56-8
Tranilast sodium acts as an anti-atopic agent.
Crisdesalazine Chemical Structure
BCP44811 Crisdesalazine 927685-43-6
Crisdesalazine, also known as AAD-2004, is a microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitor potentially for the treatment of Alzheimer's type dementia, Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Arthritis, Depression, Diabetes and Pancreatitis.
Prostaglandin G2 Chemical Structure
BCP42810 Prostaglandin G2 51982-36-6
Prostaglandin G2 is a prostaglandins G.
Pizuglanstat Chemical Structure
BCP42640 Pizuglanstat 1244967-98-3
Pizuglanstat is a hematopoietic prostaglandin synthase inhibitor.
BAY 1316957 Chemical Structure
BCP40674 BAY 1316957 1613264-40-6
BAY-1316957 is a highly potent, selective, orally available human prostaglandin E2 receptor subtype 4 (hEP4-R) antagonist (IC50= 15.3 nM ) with excellent drug metabolism and pharmacokinetics properties.
U-46619 Chemical Structure
BCP39866 U-46619 56985-40-1
U46619 is a PGH2 (TXA2) analog that is a potent and stable thromboxane A2 (TP) receptor agonist (EC50 = 0.035 μM).
BGC-20-1531 Chemical Structure
BCP37893 BGC-20-1531 1186532-61-5
BGC-20-1531 is a EP4 antagonist for the treatment of acute migraine.
ONO-8130 Chemical Structure
BCP37875 ONO-8130 459841-96-4
ONO-8130 is an orally available EP1 receptor antagonist.
DG-041 Chemical Structure
BCP35669 DG-041 861238-35-9
DG 041 inhibits PGE2 facilitation of platelet aggregation in vitro and ex vivo. Displays good plasma and metabolic stability.
123下一页末页共 102 条记录 1 / 11 页